Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEGEND BIOTECH CORPORATION

(LEGN)
  Rapport
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op LEGEND BIOTECH CORPORATION
02/10Legend Biotech : Research and Development Day 2022
28/09Legend Biotech - CARVYKTI Receives Approval from Japan's Ministry of Health, Labour and..
28/09Japan Approves Genscript Biotech's Chimeric Antigen Receptor T Cell Therapy
27/09Legend Biotech's Cancer Drug Carvykti Gets Japanese Approval to Treat Certain Adults wi..
27/09CARVYKTI™ (ciltacabtagene autoleucel) Receives Approval from Japan's Ministry of ..
27/09Legend Biotech Corporation Announces that CARVYKTI™ (ciltacabtagene autoleucel) Re..
27/09Legend Biotech : CARVYKTI™ (ciltacabtagene autoleucel) Receives Approval from Japan'..
26/09Stock Futures Point to Weaker US Session as Growth Worries Weigh; Asia, Europe Slide
26/09Wall Street Leans Back Pre-Bell; Futures Red, Europe Down, Asia Lower
16/09Legend Biotech : PROXY STATEMENT - Form 6-K
16/09Genscript Biotech Unit to Hold Research and Development Day in New York; Shares Slip 5%
15/09Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022
15/09Legend Biotech : to Host 2022 R&D Day on Monday, October 3, 2022
19/08Legend Biotech : Announces Participation in Upcoming Investor Conferences - Form 6-K
19/08Legend Biotech Announces Participation in Upcoming Investor Conferences
05/08Legend Biotech Sees Adjusted Loss in H1
05/08Legend Biotech : Announces Preliminary Results for the Six-Months Ended June 30, 2022 - Fo..
05/08Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2022
05/08Legend Biotech Corporation Provides Earnings Guidance for the Six Months Ended June 30,..
04/08Legend Biotech : Appoints Three New Directors and Elects New Chairman of the Board - Form ..
04/08Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
04/08Legend Biotech Corporation Announces Board Changes
01/08Genscript Biotech Unit Completes Follow-On Offering
27/07Legend Biotech : Announces Pricing of Public Offering - Form 6-K
27/07Genscript Bio's Nasdaq-listed Unit Prices Stock Offering to Raise $350 Million
27/07Legend Biotech Prices Offering at $43/ADS, Expects Gross Proceeds of $350 Million
27/07Legend Biotech Corporation Announces Pricing of Public Offering
26/07Legend Biotech Plans $250 Million Offering -- Shares Drop Amid Heavy Trading Volume
26/07Legend Biotech Plans $250 Million Offering -- Shares Drop in Pre-Market Trading
26/07Genscript Biotech's Nasdaq-listed Unit Plans $250 Million Stock Offering
25/07Legend Biotech : Announces Proposed Public Offering - Form 6-K
25/07Legend Biotech Corporation Announces Proposed Public Offering
22/07Genscript Biotech Unit Logs $24 Million in Q2 Sales of Immunotherapy; Shares Slip 3%
21/07Legend Biotech : Announces Preliminary Sales for CARVYKTI™ for the Quarter Ended Jun..
13/07Legend Biotech : AMENDMENT NO. 1 TO INTERIM PRODUCT SUPPLY AGREEMENT - Form 6-K
08/07GenScript Biotech Unit Terminates Phase 1 Study for Lymphoma Therapy; Shares Down 3%
07/07Legend Biotech : Announces Termination of its Phase 1 Clinical Trial Under Investigational..
07/07Legend Biotech Corporation Legend Biotech Announces Termination of Its Phase 1 Clinical..
17/06Legend Biotech Shares Rise After BMO Capital Starts Coverage
06/06Genscript Biotech Unit Presents Updated Study Results of Cancer Therapy at US Oncology ..
06/06Legend Biotech : Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable..
04/06Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses wit..
04/06Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses wit..
03/06Legend Biotech Says FDA Approves Investigational New Drug Application for LB1908 to Tre..
03/06Legend Biotech : Announces U.S. FDA Clearance of IND Application for Solid Tumor CAR-T, LB..
03/06Legend Biotech Announces U.S. FDA Clearance of IND Application for Solid Tumor CAR-T, L..
03/06Legend Biotech Corporation Announces U.S. FDA Clearance of IND Application for Solid Tu..
02/06Legend Biotech : to Host Investors at the 2022 American Society of Clinical Oncology (ASCO..
01/06Legend Biotech Q1 Loss Narrows as Revenue Increases; Shares Rise Pre-Bell
01/06Legend Biotech : Reports First Quarter 2022 Financial Results and Recent Highlights - Form..
01/06Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights
01/06Earnings Flash (LEGN) LEGEND BIOTECH Reports Q1 Loss $-0.13
01/06Legend Biotech Corporation Reports Earnings Results for the First Quarter Ended March 3..
31/05Legend Biotech to Host Investors at the 2022 American Society of Clinical Oncology (ASC..
30/05Legend Biotech’s Cancer Drug Wins Approval in EU
27/05CARVYKTI® (Ciltacabtagene Autoleucel) erhält von der Europäischen Kommission bedingte Z..
26/05Le CARVYKTI® (ciltacabtagène autoleucel) reçoit l'approbation conditionnelle de la Comm..
26/05Legend Biotech : CARVYKTI® (ciltacabtagene autoleucel) Granted Conditional Approval by the..
26/05Legend Biotech Receives Conditional European Commission Approval for Multiple Myeloma D..
26/05CARVYKTI® (ciltacabtagene autoleucel) Granted Conditional Approval by the European Comm..
26/05European Commission Grants Marketing Authorization to CARVYKTI of Legend Biotech Corpor..
18/05Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma Wit..
10/05Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%
09/05Legend Biotech Names New CFO
09/05Legend Biotech Appoints Lori Macomber as Chief Financial Officer
09/05Legend Biotech Appoints Lori Macomber as Chief Financial Officer
06/05Legend Biotech Announces Participation in Upcoming Investor Conferences
22/04Genscript Biotech Unit Receives $50 Million Milestone Payment from Janssen Biotech
21/04Legend Biotech Gets $50 Million Milestone Payment Under Deal With Janssen Biotech for C..
21/04Legend Biotech : Achieves Milestone Under Collaboration Agreement with Janssen Biotech, In..
21/04Legend Biotech Achieves $50 Million Milestone Payment Under Janssen Deal
03/04Legend Biotech Announces Executive Changes
01/04Legend Biotech : Announces Appointment of Global Head of Research and Early Development - ..
01/04Legend Biotech Announces Appointment of Global Head of Research and Early Development
01/04Legend Biotech Corporation Announces Appointment of Guowei Fang as Global Head of Resea..
25/03MÄRKTE USA/Uneinheitlich - Zurückhaltung vor dem Wochenende
25/03LATE BRIEFING - Unternehmen und Märkte -2-
25/03MÄRKTE USA/Leichte Abgaben - Anfangsgewinne nicht verteidigt
25/03MÄRKTE USA/Börsen zum Start zurückhaltend
25/03Legend Biotech Gets Positive CHMP Opinion for Carvykti for Relapsed, Refractory Multipl..
25/03J&J's Janssen, Legend Get CHMP Backing for Carvykti Blood Cancer Drug
25/03J&J und Legend erhalten Zulassungsempfehlung für Krebsmittel in der EU
25/03Legend Biotech : CARVYKTI® (ciltacabtagene autoleucel) Receives Positive CHMP Opinion for ..
25/03CARVYKTI® (ciltacabtagene autoleucel) Receives Positive CHMP Opinion for the Treatment ..
25/03Legend Biotech Corporation's CARVYKTI® (Ciltacabtagene Autoleucel) Receives Positive CH..
25/03European drug regulator clears J&J, Legend's CAR-T therapy
25/03European drugs regulator recommends J&J and Legend Biotech's cancer therapy
23/03Flanders Investment and Trade décerne à Legend Biotech le titre de Newcomer of the Year
23/03Flandern Investment and Trade kürt Legend Biotech zum Newcomer des Jahres
23/03Flanders Investment and Trade Names Legend Biotech Newcomer of the Year
21/03Sector Update: Health Care Stocks Mixed Pre-Bell Monday
18/03Legend Biotech : Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Hi..
18/03Legend Biotech Q4 Loss Widens, Revenue Slips YOY
18/03Legend Biotech Corporation Reports Earnings Results for the Full Year Ended December 31..
18/03Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent H..
18/03Earnings Flash (LEGN) LEGEND BIOTECH Reports Q4 Loss $-0.30 per Share
18/03Legend Biotech Corporation Reports Earnings Results for the Fourth Quarter Ended Decemb..
17/03Certain Warrants of Legend Biotech Corporation are subject to a Lock-Up Agreement Endin..
17/03Certain Restricted Share Units of Legend Biotech Corporation are subject to a Lock-Up A..
17/03Certain Options of Legend Biotech Corporation are subject to a Lock-Up Agreement Ending..
Volgende evenement op LEGEND BIOTECH CORPORATION